Qiming Venture Partners is a prominent venture capital firm established in 2006 and headquartered in Shanghai, with additional offices in Beijing, Suzhou, and Hong Kong. The firm specializes in investing in early to growth-stage companies across various sectors, including media and internet, information technology, consumer and retail, healthcare, and clean technology in China. Since its inception, Qiming has built a reputation as a leading investment firm in the region, managing multiple funds with over $1 billion in assets. The firm aims to support promising entrepreneurs and innovative businesses, contributing to the development of China's dynamic economic landscape.
Tripod is a Contract Research Organization in the biopharmaceutical space that provides preclinical research services for global pharma companies, R&D enterprises and institutes, and medical device developers. Tripod (TPR) is dedicated to nonclinical research (drug safety evaluation) for the candidates of new chemical entity (NCE), food additives, biologics，pesticides，veterinary drugs, and new cosmetics.
Talaris Therapeutics is a operator of a biotechnology company engaged in the development of innovative cellular therapies. The company's proprietary allogeneic cell therapy product has shown to induce tolerance in recipients of solid organ transplants from unmatched and unrelated donors, enabling living donor kidney transplant recipients to wean completely off immunosuppression one year after transplant.
Talaris Therapeutics is a operator of a biotechnology company engaged in the development of innovative cellular therapies. The company's proprietary allogeneic cell therapy product has shown to induce tolerance in recipients of solid organ transplants from unmatched and unrelated donors, enabling living donor kidney transplant recipients to wean completely off immunosuppression one year after transplant.
Founded in January 2018, Beijing Tianfutong Education Technology Co., Ltd. is an excellent technical and operational talent from education companies such as New Oriental, Good Future, and Gaosi, as well as outstanding technical talents from Internet companies such as Baidu, Sohu, and Meituan. Founded a new online education brand. Based on original quality education content and technology-driven, we provide high-quality online mathematics thinking learning content and services for children aged 3-12.
WindMIL Therapeutics, Inc. is a biotechnology company that specializes in developing innovative cell therapies for cancer patients, focusing on insights from bone marrow immunology. Established in 2015 and based in Princeton, New Jersey, the company utilizes its proprietary platform to create a new class of therapies known as Marrow Infiltrating Lymphocytes (MILs). These therapies are derived from memory T cells located in the bone marrow, aiming to provide life-saving treatment options for individuals battling cancer.
SMTP Technology Co., Ltd. specializes in the research, development, and manufacturing of orthopedic medical instruments, with a particular emphasis on ultrasonic osteotomy surgery instruments. Established in 2011 and headquartered in Zhangjiagang, China, the company aims to enhance surgical outcomes through innovative medical devices. SMTP Technology markets its products through a network of medical product distributors, striving to offer improved solutions for both surgeons and patients in the orthopedic field.
SMTP Technology Co., Ltd. specializes in the research, development, and manufacturing of orthopedic medical instruments, with a particular emphasis on ultrasonic osteotomy surgery instruments. Established in 2011 and headquartered in Zhangjiagang, China, the company aims to enhance surgical outcomes through innovative medical devices. SMTP Technology markets its products through a network of medical product distributors, striving to offer improved solutions for both surgeons and patients in the orthopedic field.
Tellgen Corporation researches and develops, manufactures, and distributes IVDs in China and internationally. It offers tumor markers, human papilloma virus test kits, ToRCH products, Y chromosome microdeletions test kits, and multiplex immunoassay systems. The company was founded in 2003 and is based in Shanghai, China.
Timesafer is an electronic authentication and information security service provider that provides dynamic password and password protection services through mobile phone secrets. The mobile phone secrets a set of 6-digit dynamic passwords every 60 seconds or 30 seconds through the smartphone screen to provide account services to the user.
Mutto Optronics Corporation, founded in 2008 and headquartered in Taipei, Taiwan, operates in two main business areas. The company manufactures and sells stainless steel kitchen utensils and refined cutlery sets across the United States, China, Taiwan, and other international markets. Additionally, Mutto Optronics engages in the OEM and ODM manufacturing of knives. The company also has a presence in the touch panel market, providing both resistive and capacitive touch panels for mobile phones and tablets. Through these diverse operations, Mutto Optronics serves a wide range of consumer needs globally.
Hangzhou Tigermed Technology Co., Ltd. is a Chinese contract research organization providing whole process clinical trial services for the research and development of pharmaceutical products.
Since its inception, the company is dedicated to the provision of medical research and development services that enables clients to reduce the risk and cost of R&D, while advancing the process of marketization. With 21 sub-companies spread across 43 main cities in the world, including China, America, Canada, Japan, Australia, Korea, and more, Tigermed owns a professional team of more than 900 people that constructs the operating instruction that meets international standards. Tigermed has succeeded in providing more than 300 customers with over 300 clinical trial services by the end of 2013. For its participation in 42 domestic drugs, Tigermed is honoured as an “Innovation-type CRO.”
Taomee Holdings Limited is a children's entertainment and media company in China that aims to create exceptional entertainment experiences for children that are fun, safe, and trusted by parents.
It leverages content development capability, professional knowledge of designing virtual worlds, and broad operating experience in Chinese children's entertainment market to develop memorable and iconic characters, images, and storylines that have attracted a loyal following among children between the ages of 5 and 15.
Today, Mole's World and Seer stories and characters have reached more than 100 million children through Taomee’s award-winning online communities, 61.com.
Taomee was founded in October 2007 and is headquartered in Shanghai. It received its first round of overseas investments of US$5 million from Sequoia Capital in June 2009. In June 2011, Taomee completed an initial public offering on the New York Stock Exchange, becoming the first Chinese children-themed stock to go public in the U.S.
Hangzhou Tigermed Technology Co., Ltd. is a Chinese contract research organization providing whole process clinical trial services for the research and development of pharmaceutical products.
Since its inception, the company is dedicated to the provision of medical research and development services that enables clients to reduce the risk and cost of R&D, while advancing the process of marketization. With 21 sub-companies spread across 43 main cities in the world, including China, America, Canada, Japan, Australia, Korea, and more, Tigermed owns a professional team of more than 900 people that constructs the operating instruction that meets international standards. Tigermed has succeeded in providing more than 300 customers with over 300 clinical trial services by the end of 2013. For its participation in 42 domestic drugs, Tigermed is honoured as an “Innovation-type CRO.”